The first consulting & advisory company expert in HA and Chitosan 

Annecy, July 15, 2019: Falgagen announces today the foundation of the first consulting and advisory company expert in HA and Chitosan, which serves the life sciences industries in the conception and development of Medical Devices comprising natural polymers, with a strong expertise in HA and Chitosan. 

Located in the heart of the “HA Valley”, Falgagen team is composed of scientists and medical device strategists and are committed to provide their partners with customised services in Research and Development (Innovation, Formulation), Industrial Operations (Set up and Improvement), and Business Development (In- & Out-licensing, Due-Diligence). 

“We are at the forefront of a new era in the Medical Device industry” said Thomas Fevre, Managing Partner and Co-Founder at Falgagen. “Any market player involved in the marketing of Hyaluronic Acid- or Chitosan-based products, will have to embrace a much larger regulatory responsibility; these actors will have to quickly master technical competences on these molecules to continue innovating. We are here to support them integrating efficiently advanced experiences and competences”. 

“HA applications are continuously expanding” said Alexandre Adamczewski, Partner Innovation & Development, and Co-Founder at Falgagen. “The safety profile of this molecule is exceptionally good, which gives wonderful perspectives in further applications. Falgagen is the partner of choice to develop safe injectable medical devices”. 

“Chitosan is a complex and interesting polymer” said Gautier Lalevée, Partner Innovation & Development, and Co-Founder at Falgagen. “Its use in injectable products is still rather limited, however its potential, alone or in association with hyaluronic acid, is important and major innovations can be brought using it.” 

For more information, please visit : www.falgagen.com or follow @Falgagen on LinkedIn. 

About Falgagen SAS : 

Falgagen is the first consulting and advisory company expert in Hyaluronic Acid and Chitosan, which support the Life Sciences industries, in the conception and development of medical devices comprising natural polymers, with a strong expertise in Hyaluronic Acid and Chitosan. 

Contact: Thomas Fevre – t.fevre@falgagen.com 

Leave a Reply

Your email address will not be published. Required fields are marked *

Post comment